| Literature DB >> 27190449 |
Kanichirou Murata1, Hitoshi Asai2, Pleiades Tiharu Inaoka2, Dai Nakaizumi3.
Abstract
[Purpose] The goal of this study was to investigate the efficacy of stepping-in-place training using a foot lifting assist device on the walking gait of chronic hemiparetic stroke patients. [Subjects] Seven patients with chronic hemiplegic stroke (age 80.9±4.9 years) who were attending a local adult daycare facility participated in this study. [Methods] The participants had 2 or 16 weeks of intervention after a baseline period of 2 weeks. Evaluations were performed before the baseline period and before and after the intervention period. The evaluation consisted of a two-dimensional motion analysis of walking and stepping-in-place exercises and a clinical evaluation.Entities:
Keywords: Chronic hemiplegia; Stepping-in-place; Walking
Year: 2016 PMID: 27190449 PMCID: PMC4868209 DOI: 10.1589/jpts.28.1170
Source DB: PubMed Journal: J Phys Ther Sci ISSN: 0915-5287
Initial characteristics of the participants
| Participants | PA | PB | PC | PD | PE | PF | PG |
|---|---|---|---|---|---|---|---|
| Gender | M | F | M | M | F | M | F |
| Age (years) | 83 | 81 | 84 | 80 | 71 | 84 | 78 |
| Weight (kg) | 56.2 | 58.1 | 55.2 | 66.4 | 59.2 | 54.7 | 50.8 |
| Time after stroke (years) | 6 | 9 | 17 | 3 | 10 | 32 | 11 |
| Type of stroke | Ischemic | Ischemic | Hemorrhagic | Ischemic | Ischemic | Ischemic | Hemorrhagic |
| Hemiparetic side | Left | Right | Right | Right | Right | Right | Right |
| MAS | |||||||
| Hip | 1 | 1 | 1 | 3 | 0 | 2 | 1 |
| Knee | 2 | 0 | 1 | 3 | 1 | 1 | 2 |
| Ankle | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| LE-FMA | 15 | 21 | 9 | 9 | 19 | 11 | 25 |
| Use of an orthosis | AFO | ― | ― | AFO | ― | AFO | AFO |
| Walking aid | T-cane | T-cane | T-cane | Quad-cane | T-cane | T-cane | T-cane |
| FAC | 3 | 5 | 4 | 2 | 4 | 3 | 4 |
MAS: Modified Ashworth Scale (0–5); LE-FMA: lower extremity subscale of the Fugl-Meyer Assessmen; FAC: Functional Ambulation Category (0–5); AFO: ankle-foot orthosis
Fig. 1.The device that assists the lifting of the foot heel: (A) picture of the device, (B) schematic illustration of the device (side view), (C) schematic illustration of the device (rear view) and adjustment by the number of springs
Clinical assessment and the kinematic parameters of walking and stepping-in-place of each participant
| Participants | PA | PB | PC | PD | PE | PF | PG | |
|---|---|---|---|---|---|---|---|---|
| Clinical assessment | ||||||||
| Walking speed (m/sec) | Baseline | 0.65 | 0.58 | 0.31 | 0.16 | 0.4 | 0.26 | 0.23 |
| Eva3 | 0.68 | 0.59 | 0.30 | 0.17 | 0.41 | 0.21 | 0.26 | |
| (+4.6) | (+1.7) | (−3.2) | (+6.3) | (+2.5) | (−19.2) | (+13.0) | ||
| Eva4 | 0.75 | 0.46 | ||||||
| (+15.4) | (+15.0) | |||||||
| Cadence (steps/min) | Baseline | 102.5 | 84 | 75.1 | 43.9 | 78.1 | 56.7 | 74.6 |
| Eva3 | 98.2 | 88.6 | 69.1 | 46.6 | 78.5 | 51.0 | 76.0 | |
| (−4.2) | (+5.5) | (−8.0) | (+6.2) | (+0.5) | (−10.1) | (+1.9) | ||
| Eva4 | 98.9 | 86 | ||||||
| (−3.5) | (+10.1) | |||||||
| LE-FMA (score/34) | Baseline | 14.5 | 21 | 9 | 9 | 19.5 | 11 | 24.5 |
| Eva3 | 15 | 21 | 9 | 9 | 20 | 9 | 25 | |
| Eva4 | 16 | 21 | ||||||
| Walking | ||||||||
| 1 GC duration (sec) | Baseline | 1.18 | 1.56 | 1.69 | 2.45 | 1.72 | 2.77 | 1.68 |
| Eva3 | 1.27 | 1.41 | 1.89 | 2.34 | 1.63 | 2.66 | 1.71 | |
| (+7.6) | (−9.6) | (+11.8) | (−4.5) | (−5.2) | (−4.0) | (+1.8) | ||
| Eva4 | 1.23 | 1.41 | ||||||
| (+4.2) | (−18.0) | |||||||
| Swing phase duration (sec) | Baseline | 0.41 | 0.53 | 0.57 | 0.52 | 0.57 | 0.54 | 0.48 |
| Eva3 | 0.5 | 0.4 | 0.72 | 0.34 | 0.6 | 0.59 | 0.52 | |
| (+22.0) | (−24.5) | (+26.3) | (−34.6) | (+5.3) | (+9.3) | (+8.3) | ||
| Eva4 | 0.5 | 0.52 | ||||||
| (+22.0) | (−8.8) | |||||||
| %Sw (%) | Baseline | 34.8 | 33.9 | 33.7 | 22.5 | 33.2 | 19.6 | 28.8 |
| Eva3 | 38.9 | 28.5 | 37.9 | 14.4 | 37 | 22.1 | 30.6 | |
| (+11.8) | (−15.9) | (+12.5) | (−36.0) | (+11.4) | (+12.8) | (+6.3) | ||
| Eva4 | 40.7 | 37.1 | ||||||
| (+17.0) | (+11.7) | |||||||
| Step length (m) | Baseline | 0.29 | 0.31 | 0.34 | 0.1 | 0.32 | 0.24 | 0.17 |
| Eva3 | 0.3 | 0.29 | 0.35 | 0.07 | 0.31 | 0.20 | 0.17 | |
| (+3.4) | (−6.5) | (+2.9) | (−30.0) | (−3.1) | (−16.7) | (±0) | ||
| Eva4 | 0.35 | 0.34 | ||||||
| (+20.7) | (+6.3) | |||||||
| Stepping-in-place | ||||||||
| L5-amp (m) | Baseline | 0.14 | 0.13 | 0.09 | 0.08 | 0.14 | 0.11 | |
| Eva3 | 0.12 | 0.12 | 0.12 | 0.05 | 0.13 | 0.1 | ||
| (−14.3) | (−7.7) | (+33.3) | (−37.5) | (−7.1) | (−9.1) | |||
| Eva4 | 0.12 | 0.06 | ||||||
| (−14.3) | (−25.0) | |||||||
| HO-HC duration (sec) | Baseline | 0.44 | 0.19 | 0.32 | 0.32 | 1.04 | 0.27 | |
| Eva3 | 0.12 | 0.12 | 0.49 | 0.25 | 0.85 | 0.17 | ||
| (−72.7) | (−36.8) | (+53.1) | (−21.9) | (−18.3) | (−37.0) | |||
| Eva4 | 0.11 | 0.17 | ||||||
| (−75.0) | (−46.9) |
Eva1: evaluation performed before phase A; Eva2: evaluation performed before phase B; Eva2: evaluation performed after phase B; Eva4: evaluation performed 16 weeks after intervention. The baseline value is the mean of Eva1 and Eva2. LE-FMA: lower extremity subscale of the Fugl-Meyer Assessment; GC: gait cycle, L5-amp: lateral amplitude of L5; HO-HC duration: time from non-paretic heel contact to paretic heel off; %Sw(%): percentage of the swing phase in a gait cycle. The values in parentheses indicate the percentages of increase or decrease of Eva3 and Eva4 compared with the baseline.